Human Pericytes for Ischemic Heart Repair123. (12th February 2013)
- Record Type:
- Journal Article
- Title:
- Human Pericytes for Ischemic Heart Repair123. (12th February 2013)
- Main Title:
- Human Pericytes for Ischemic Heart Repair123
- Authors:
- Chen, Chien‐Wen
Okada, Masaho
Proto, Jonathan D.
Gao, Xueqin
Sekiya, Naosumi
Beckman, Sarah A.
Corselli, Mirko
Crisan, Mihaela
Saparov, Arman
Tobita, Kimimasa
Péault, Bruno
Huard, Johnny - Abstract:
- <abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <p>Human microvascular pericytes (CD146<sup>+</sup>/34<sup>−</sup>/45<sup>−</sup>/56<sup>−</sup>) contain multipotent precursors and repair/regenerate defective tissues, notably skeletal muscle. However, their ability to repair the ischemic heart remains unknown. We investigated the therapeutic potential of human pericytes, purified from skeletal muscle, for treating ischemic heart disease and mediating associated repair mechanisms in mice. Echocardiography revealed that pericyte transplantation attenuated left ventricular dilatation and significantly improved cardiac contractility, superior to CD56+ myogenic progenitor transplantation, in acutely infarcted mouse hearts. Pericyte treatment substantially reduced myocardial fibrosis and significantly diminished infiltration of host inflammatory cells at the infarct site. Hypoxic pericyte‐conditioned medium suppressed murine fibroblast proliferation and inhibited macrophage proliferation in vitro. High expression by pericytes of immunoregulatory molecules, including interleukin‐6, leukemia inhibitory factor, cyclooxygenase‐2, and heme oxygenase‐1, was sustained under hypoxia, except for monocyte chemotactic protein‐1. Host angiogenesis was significantly increased. Pericytes supported microvascular structures in vivo and formed capillary‐like networks with/without endothelial cells in three‐dimensional cocultures. Under hypoxia, pericytes dramatically<abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <p>Human microvascular pericytes (CD146<sup>+</sup>/34<sup>−</sup>/45<sup>−</sup>/56<sup>−</sup>) contain multipotent precursors and repair/regenerate defective tissues, notably skeletal muscle. However, their ability to repair the ischemic heart remains unknown. We investigated the therapeutic potential of human pericytes, purified from skeletal muscle, for treating ischemic heart disease and mediating associated repair mechanisms in mice. Echocardiography revealed that pericyte transplantation attenuated left ventricular dilatation and significantly improved cardiac contractility, superior to CD56+ myogenic progenitor transplantation, in acutely infarcted mouse hearts. Pericyte treatment substantially reduced myocardial fibrosis and significantly diminished infiltration of host inflammatory cells at the infarct site. Hypoxic pericyte‐conditioned medium suppressed murine fibroblast proliferation and inhibited macrophage proliferation in vitro. High expression by pericytes of immunoregulatory molecules, including interleukin‐6, leukemia inhibitory factor, cyclooxygenase‐2, and heme oxygenase‐1, was sustained under hypoxia, except for monocyte chemotactic protein‐1. Host angiogenesis was significantly increased. Pericytes supported microvascular structures in vivo and formed capillary‐like networks with/without endothelial cells in three‐dimensional cocultures. Under hypoxia, pericytes dramatically increased expression of vascular endothelial growth factor‐A, platelet‐derived growth factor‐β, transforming growth factor‐β1 and corresponding receptors while expression of basic fibroblast growth factor, hepatocyte growth factor, epidermal growth factor, and angiopoietin‐1 was repressed. The capacity of pericytes to differentiate into and/or fuse with cardiac cells was revealed by green fluorescence protein labeling, although to a minor extent. In conclusion, intramyocardial transplantation of purified human pericytes promotes functional and structural recovery, attributable to multiple mechanisms involving paracrine effects and cellular interactions. S<sc>TEM</sc> C<sc>ELLS</sc><italic>2013;31:305–316</italic></p> </abstract> … (more)
- Is Part Of:
- Stem cells. Volume 31:Number 2(2013:Feb.)
- Journal:
- Stem cells
- Issue:
- Volume 31:Number 2(2013:Feb.)
- Issue Display:
- Volume 31, Issue 2 (2013)
- Year:
- 2013
- Volume:
- 31
- Issue:
- 2
- Issue Sort Value:
- 2013-0031-0002-0000
- Page Start:
- 305
- Page End:
- 316
- Publication Date:
- 2013-02-12
- Subjects:
- Cloning -- Periodicals
Clone cells -- Periodicals
Stem cells -- Periodicals
Cell Differentiation -- Periodicals
Cell Division -- Periodicals
Clone Cells -- Periodicals
Hematopoietic Stem Cells -- Periodicals
Stem Cells -- Periodicals
571.84 - Journal URLs:
- https://academic.oup.com/stmcls ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/stem.1285 ↗
- Languages:
- English
- ISSNs:
- 1066-5099
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8464.133510
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3488.xml